The validated brain health model links mechanistic pathways with population data and reproduces neuronal density patterns in an independent cohort support its use as a framework for studying brain aging and investigating how Alzheimer's disease related pathological changes may emerge with aging.
Abstract
Background Understanding the mechanisms underlying brain aging and age-related pathological changes is essential for advancing brain health research. Our group previously developed a mechanistic mathematical model of healthy brain, Chamberland et al. (2024) that integrates key biological processes involved in normal aging, from which Alzheimer's disease (AD) related changes may emerge naturally. Objectives To characterize and validate this brain model by evaluating its sensitivity, calibrating its parameters, and assessing generalizability in independent populations. Methods The model represents the evolution of key biological processes associated with brain aging, including amyloid beta (A{beta}), tau pathologies, neuroinflammation, and neuronal death. After identifying the 30 most influential parameters, we calibrated the model using cognitively normal (CN) participants from the AD Neuroimaging Initiative (ADNI) database (n = 211) by minimizing a loss function composed of three outcomes (AB) plaques, tau tangles, and neuronal density). The calibrated model was then applied to the UK Biobank cohort (n = 35,899) of normal controls (aged 44-82 years). The effects of sex and APOE were evaluated using stratified simulations. Results Parameter calibration significantly reduced the prediction errors for A{beta} and tau. Neuronal density predictions showed strong agreement in the UK Biobank cohort. The variance decomposition identified APOE status as a major contributor to variability in A{beta}. Conclusion Our validated brain health model links mechanistic pathways with population data and reproduces neuronal density patterns in an independent cohort. These findings support its use as a framework for studying brain aging and investigating how Alzheimer's disease related pathological changes may emerge with aging.
Brain health is a state of physiological functioning of the organ that allows individuals to fully achieve their age-related potential. Throughout life, a wide range of endogenous and exogenous factors can influence positively and negatively brain health. Among them, age is undoubtedly one of the most important, partic...
Mohammad Shahadat Hossain, Domenico Praticò· Journal of Alzheimer's disea...· 0 citations
Alzheimer’s disease (AD) is a progressive neurological disorder and the leading cause of dementia, affecting millions globally. As populations continue to age, AD prevalence is expected to rise significantly, placing substantial burdens on healthcare systems. Early detection of cognitive decline is essential, as interv...
Samaneh Rezaeimanesh, Mohammad Fili, Gui-Ping Hu et al.· IISE Annual Conference &...· 0 citations
Brain aging provides an integrative marker of systemic health, but whether regional patterns outperform whole-brain approaches remains unknown. Here, we show that regional brain age signatures achieve superior mortality prediction through identifiable neurovascular-immune mechanisms in 1,240 community-dwelling adults f...
We developed a machine learning framework grounded in a computational model of brain function and FDG-PET imaging to predict Alzheimer’s disease (AD)-type tau across AD and related disorders (ADRD). The model was trained on 1088 research participants spanning normal aging and ADRD with FDG-PET and flortaucipir-PET...
Nick Corriveau-Lecavalier, Ge-Meng Zhang, H. Botha et al.· Nature Communications· 0 citations